Wake Forest University Baptist Medical Center
CareersFind a DoctorMake an AppointmentDepartmentsDirections & ParkingGiftsContact UsPRINT
 


The Wake Forest Baptist Approach

Abdominal Cancer
(Including Esophageal, Stomach, Colon, Rectal, and Pancreatic Cancers)

Management of abdominal cancers focuses on preventive measures, early detection and treatment through numerous clinical trials developed locally, regionally and nationally. New drug and radiation therapies, and combined modality treatments, are being explored through these trials.

Our surgical oncologists are pioneering a number of innovative treatments including:

Intraperitoneal Hyperthermic Chemotherapy

A major difficulty of treating patients with peritoneal carcinomatosis (advanced cancer of the abdomen) is that it is often not possible to remove all the cancer cells. As a result, the cancer often persists despite surgery, chemotherapy and other treatments.

Conventional surgery is ineffective because for every visible growth that surgeons remove, they leave behind dozens of microscopic cells. Chemotherapy drugs delivered through the bloodstream are too diluted by the time they reach the growths, leaving them unaffected; and the radiation dose needed to kill the cancerous cells would be too strong for healthy organs to withstand.

Since 1991, patients have been treated at Wake Forest Baptist with a promising and innovative therapy. Performed by only a handful of surgeons across the country, intraperitoneal hyperthermic chemotherapy (IPHC) is performed in concert with traditional surgery.

The logic behind the procedure is that, if cancer-fighting drugs could be put directly on the malignant cells, they are more effective.

During the procedure, the surgeon removes all visible growth from the patient’s abdomen, inserts plastic tubes in the abdominal wall and closes the incision. The tubes are attached to a pump which moves a heated anti-cancer drug fluid into the abdominal cavity and then back out for a constant flow. The heat improves the drug's effectiveness and can add years and quality of life to patients for whom there was previously no hope.  The Center has performed over 400 of these procedures, representing one of the most experienced teams worldwide.

Complex  operations on the esophagus, pancreas and rectum are commonly performed.  This makes our surgeons and center high volume providers.   We continue to investigate new methods of sphincter preservation for cancers of the rectum.   Funded multimodality research programs are linked to surgery for each of these sites.

 

Gastric cancer

Definition:

Gastric cancer is cancer that starts in the stomach.



Alternative Names:

Cancer - stomach; Stomach cancer; Gastric carcinoma; Adenocarcinoma of the stomach



Causes, incidence, and risk factors:

Several different types of cancer can occur in the stomach. The most common type is called adenocarcinoma, which starts from one of the common cell types found in the lining of the stomach. There are several types of adenocarcinoma. Because other types of gastric cancer occur much less frequently, this article focuses on adenocarcinoma of the stomach.

Adenocarcinoma of the stomach is a common cancer of the digestive tract worldwide, although it is relatively uncommon in the United States. It occurs most frequently in men over 40 years old. This form of gastric cancer is extremely common in Japan, Chile, and Iceland. The rate of most types of gastric adenocarcinoma in the United States has declined over the years. Experts think the decrease may be related to reduced intake of salted, cured, and smoked foods.

Diagnosis is often delayed bcause symptoms may not occur in the early stages of the disease, or because patients self-treat symptoms that may be common to other, less serious gastrointestinal disorders (bloating, gas, heartburn, and a sense of fullness).

Risk factors for gastric cancer are a family history of gastric cancer, Helicobacter pylori infection, blood type A, smoking, a history of pernicious anemia, a history of chronic atrophic gastritis, a condition of decreased gastric acid, and a prior history of an adenomatous gastric polyp.



Symptoms:



Signs and tests:

The following tests can help diagnose gastric cancer:



Treatment:

Surgical removal of the stomach (gastrectomy) is the only curative treatment. Radiation therapy and chemotherapy may be beneficial. A recent study showed that for many patients, chemotherapy and radiation therapy given after surgery improve the chance of a cure.

For patients in whom surgery is not an option, chemotherapy or radiation can improve symptoms but may not cure the cancer. For some patients, a surgical bypass procedure may provide relief of symptoms.



Support Groups:

The stress of illness may often be eased by joining a support group with members who share common experiences and problems. See cancer - support group and gastrointestinal disorders - support group.



Expectations (prognosis):

The outlook varies widely. Tumors in the lower stomach are more often cured than those in the higher area -- gastric cardia or gastroesophageal junction. The depth to which the tumor invades the stomach wall and whether lymph nodes are involved influence the chances of cure.

In circumstances in which the tumor has spread outside of the stomach, cure is not possible and treatment is directed toward improvement of symptoms.



Complications:

  • Fluid build up in the belly area (ascites)
  • Spread of cancer to other organs or tissues
  • Weight loss


Calling your health care provider:

Call your health care provider if symptoms of gastric cancer develop.



Prevention:

Mass screening programs have been successful in detecting disease in the early stages in Japan, where the risk of gastric cancer is very high. The value of screening in the United States and other countries with lower rates of gastric cancer is not clear.

The following may help reduce your risk of gastric cancer:

  • Don't smoke.
  • Eat a healthy, balanced diet rich in fruits and vegetables.


References:

Gunderson LL, Donohue JH, Alberts SR. Cancer of the Stomach. In: Abeloff MD, Armitage JO, Niederhuber JE, Kastan MB, McKena WG, eds. Clinical Oncology. 3rd ed. Philadelphia, Pa: Elsevier Churchill Livingstone; 2004:chap 79.




Review Date:9/4/2008
Reviewed By:Sean O. Stitham, MD, private practice in Internal Medicine, Seattle, Washington; and James R. Mason, MD, Oncologist, Director, Blood and Marrow Transplantation Program and Stem Cell Processing Lab, Scripps Clinic, Torrey Pines, California. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.

Copyright: Wake Forest University School of Medicine and North Carolina Baptist Hospitals. All rights reserved.

Medical Center Boulevard

Winston-Salem, NC 27157

The information on this Website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified healthcare provider. If you have a medical problem or a health-related question, consult your physician or call Health On-Call at 336-716-2255 or 1-800-446-2255.

Send Feedback


Home

Site Index


Last Modified: 9/19/2006